CONTRAST-INDUCED NEPHROPATHY
Clinical trials for CONTRAST-INDUCED NEPHROPATHY explained in plain language.
Never miss a new study
Get alerted when new CONTRAST-INDUCED NEPHROPATHY trials appear
Sign up with your email to follow new studies for CONTRAST-INDUCED NEPHROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New urine test may spot kidney danger before it strikes
Diagnosis CompletedThis study tested a new urine test (RENISCHEM L-FABP) to see if it can predict acute kidney injury within 2 days after heart or blood vessel procedures that use contrast dye. Researchers measured a kidney stress marker in 382 adults at higher risk. The goal was to validate the te…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Sponsor: Hikari Dx, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 13:08 UTC
-
Drug may shield kidneys from dye harm in ICU
Prevention CompletedThis study tested whether pentoxifylline, a drug that improves blood flow, can prevent kidney damage caused by contrast dye used in medical imaging. The trial included 70 adults with chronic kidney disease who were in the intensive care unit and needed contrast dye. Researchers m…
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: NA • Sponsor: Tanta University • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Pause or continue? study tests ACE inhibitor timing to prevent kidney damage
Knowledge-focused CompletedThis study looked at whether continuing or temporarily stopping the blood pressure medicine Ramipril (an ACE inhibitor) before coronary angiography affects the risk of kidney injury from the contrast dye. 44 adults were randomly assigned to either keep taking their usual dose or …
Matched conditions: CONTRAST-INDUCED NEPHROPATHY
Phase: NA • Sponsor: Tanta University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC